Cigna Corporation

🇺🇸New York Stock Exchange
Back to all articles
Cigna Corporation stock analysis CI overview
Bullish +75

Cigna (CI) Gets a Buy from Bernstein

📈 Bernstein analyst Lance Wilkes maintains a Buy rating on Cigna (CI) and sets a new price target of $358.00.

💰 The company reported quarterly revenue of $72.47 billion for the quarter ending December 31, up from $65.65 billion the prior year.

⚖️ Net profit decreased to $1.23 billion compared to $1.42 billion in the same period last year.

🤝 The wider street consensus rates Cigna as a Strong Buy with an average analyst price target of $342.62.

🩺 Analyst Lance Wilkes covers the Healthcare sector, including stocks such as Centene and CVS Health.

📊 TipRanks data indicates Wilkes has an average return of -8.7% with a 32.67% success rate on recommended stocks.

⚠️ Content is syndicated from third-party sources, including paid content and unreviewed press releases.

Bullish Signals
  • Bernstein analyst Lance Wilkes maintained a Buy rating on Cigna (CI) with a price target of $358.00, indicating strong investor confidence.
  • The Street suggests a Strong Buy analyst consensus rating for Cigna with an average price target of $342.62 across Wall Street analysts.
  • Cigna reported quarterly revenue of $72.47 billion and a net profit of $1.23 billion for the quarter ending December 31, demonstrating solid financial performance.
Risk Factors
  • Analyst Lance Wilkes at Bernstein has an average return of -8.7% on recommended stocks, suggesting the quality of his past calls may be subpar.
Full Analysis
Bernstein analyst Lance Wilkes has maintained a Buy rating on Cigna (CI) and set a price target of $358.00. Wilkes covers the Healthcare sector, with his recent recommendations including stocks such as Cigna, Centene, and CVS Health. According to TipRanks data, Wilkes has an average return of -8.7% and a 32.67% success rate on recommended stocks. The broader analyst consensus for Cigna suggests a Strong Buy rating, with an average price target of $342.62. Additionally, Bernstein had previously upgraded Cigna to Outperform from Market Perform. Cigna's most recent financial results show the company reported a quarterly revenue of $72.47 billion and a net profit of $1.23 billion for the quarter ending December 31. In comparison to the same period last year, the company earned a revenue of $65.65 billion but had a net profit of $1.42 billion. The news follows broader market updates, including midday reports that Dick's Sporting Goods and Dollar General reported quarterly beats. The article also references other market movements, noting that CVS was upgraded while General Mills was downgraded by Wall Street analysts. Additional headlines mentioned include a lawsuit where a Department sues New York-Presbyterian over allegedly anticompetitive contracts, and various calendar items regarding oil prices and Canadian oil stocks. The content includes standard disclaimers indicating that the Globe and Mail has not reviewed this third-party content and may receive compensation for its placement on the site.